Key result
Diabetic autonomic neuropathy affects ~36% of ambulatory type 2 diabetes patients, often while asymptomatic.
Why the study?
Diabetic autonomic neuropathy is a serious complication of diabetes with significant morbidity and mortality, but its status in ambulatory type 2 diabetics in tertiary care is not well characterized.
Population
108 ambulatory type 2 diabetes patients in a tertiary care setting
Comparison
Patients with overt symptoms of autonomic neuropathy vs without symptoms
Design
Single-arm prospective observational study
Follow-up
12 months
Authors
Loading...
DAN prevalence of 36% in ambulatory type 2 diabetes signals need for vigilance; leaves open whether screening improves outcomes.
Observational (n=108)
Saha et al. (2023) conducted an observational in Type 2 diabetes mellitus (n=108). Type 2 diabetes mellitus was evaluated on Prevalence of diabetic autonomic neuropathy (DAN). The overall prevalence of diabetic autonomic neuropathy in ambulatory patients with type 2 diabetes was 36%, detectable even during the asymptomatic phase using simple cardiovascular tests.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: